Dexamethasone & Ketamine as Adjuvants to Bupivacaine for Incisional Infiltration in Pediatric Abdominal Operations

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

December 5, 2020

Primary Completion Date

March 5, 2021

Study Completion Date

April 15, 2021

Conditions
Pediatric ALL
Interventions
DRUG

Bupivacaine

Bupivacaine 0.25% 1ml/kg will be injected subcutaneously by the surgeon before wound closure.

DRUG

Ketamine

In addition to bupivacaine, ketamine 1mg/kg diluted in 10 ml normal saline will be injected subcutaneously by the surgeon before wound closure. Bupivacaine and ketamine will be administered using two separate syringes.

DRUG

Dexamethasone

In addition to bupivacaine, dexamethasone 0.2mg/kg diluted in 10 ml normal saline will be injected subcutaneously by the surgeon before wound closure. Bupivacaine and dexamethsone will be administered using two separate syringes.

Trial Locations (1)

11591

Ain Shams university hospitals, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT05190952 - Dexamethasone & Ketamine as Adjuvants to Bupivacaine for Incisional Infiltration in Pediatric Abdominal Operations | Biotech Hunter | Biotech Hunter